Results from current studies, however, demonstrate that TR4 can function as a tumor enhancer via regulating the stem cell population and EMT to promote PCa initiation if PPARG is deleted or its function is suppressed by the GW9662 inhibitor. Here, PPARG is linked to posterior cortical atrophy.